&nbsp;

Sep 2025

Drug

aldesleukin

Other Name(s): Proleukin® (interleukin-2)

Quick Link(s):

Apr 2024

Drug

siltuximab

Other Name(s): Sylvant®

Quick Link(s):

Mar 2025

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Regimen

ALDE(Intralesional)

Cancer Type:

Skin,

Melanoma

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma

Drugs Used:

aldesleukin

Quick Link(s):

Regimen Monograph

May 2019

Regimen

AZCT

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML),

Myelodysplastic Syndrome (MDS),

Myeloproliferative Neoplasms (MPNs)

Intent: Palliative

Funding:

New Drug Funding Program

Azacitidine - Intermediate-2 and high-risk myelodysplastic syndrome (MDS)

New Drug Funding Program

Azacitidine - Acute Myeloid Leukemia (AML)

New Drug Funding Program

Azacitidine - Acute Myeloid Leukemia (AML) Greater Than 30% Blasts

Drugs Used:

azaCITIDine

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

AC-DOCE; AC-DOCE+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

AC-PACL(W); AC-PACL(W)+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

AC-PACL(DD); AC-PACL(DD)+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet (AC-PACL(DD)), Patient Info Sheet (AC-PACL(DD)+TRAS)

Jan 2024

Regimen

AC-PACL; AC-PACL+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

SILT

Cancer Type:

Hematologic,

Rare Diseases

Intent: Palliative

Funding:

New Drug Funding Program

Siltuximab - Multicentric Castleman’s Disease (MCD)

Drugs Used:

siltuximab

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

AVEL

Cancer Type:

Skin,

Merkel Cell

Intent: Palliative

Funding:

New Drug Funding Program

Avelumab - Metastatic Merkel Cell Carcinoma

Drugs Used:

avelumab